PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Tadalafil - Erectile dysfunction

PAD Profile : Tadalafil - Erectile dysfunction

Keywords :
Phosphodiesterase type 5 inhibitors, ED, Impotence
Brand Names Include :
Cialis

Traffic Light Status

Status 1 of 2.

Status :
Green (see narrative)
Important Preferred
Formulations :
  • Tablets
Important Information :
2.5mg tadalafil is non-formulary.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Status 2 of 2.

Status :
Non Formulary
Important
Formulations :
  • 2.5mg ONCE DAILY
Important Information :
Once daily tadalafil 2.5mg is non-formulary. Sildenafil is 1st line. Tadalafil (10mg, 20mg or 5mg) is an alternative.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
NFD1
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

Committee Recommendations

Date
Committee Name
Narrative
05 June 2024
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands APC have agreed the following update for tadalafil for erectile dysfunction:

Tadalafil "as required" dosing (10mg and 20mg) has a Green traffic light status. Tadalafil and sildenafil "as required" dosing are equally preferred treatment options.

Tadalafil once daily (5mg) has a Green traffic light status. If daily dosing is not tolerated, use "as required" dosing.

Tadalafil once daily (2.5mg) is non-formulary (very costly).

NOTE: SLS endorsement is still required for tadalafil prescribing on the NHS. Patients who do not meet the SLS criteria may purchase an over-the-counter product. 

Use in combination with any other oral / non-oral treatments for erectile dysfunction is not supported

Associated BNF Codes

07. Obstetrics, Gynaecology and Urinary-Tract Disorders
07.04.05. Drugs for erectile dysfunction
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More